Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of SkQ1 Ophthalmic Solution for the Treatment of Dry Eye Syndrome

NCT03764735 is registered in ClinicalTrials.gov with Mitotech, SA as lead sponsor.

NCT NCT03764735
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03764735 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of SkQ1 Ophthalmic Solution for the Treatment of Dry Eye Syndrome
Lead sponsor
Mitotech, SA
Phase
Phase 3
Overall status
Completed
Start date
December 6, 2018
Completion date
February 9, 2019
Enrollment
452 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye syndrome